CTOs on the Move

Vertos Medical

www.vertosmed.com

 
Vertos Medical is an interventional pain company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS). mild®, its proprietary technology, is an image-guided outpatient procedure that removes a major root cause of lumbar spinal stenosis (LSS) through an incision smaller than the size of baby aspirin and doesn`t require implants, general anesthesia, or stitches. The mild® Procedure has been clinically demonstrated to have safety outcomes similar to injections with durability out to 5 years, and patients typically return to activities of daily living within 24 hours with no restrictions. mild® is nationally covered by Medicare. In November 2022, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Mehrzad Khakpour
Chief Technology Officer Profile

Funding

Vertos Medical raised $28M on 06/12/2017

Similar Companies

CellaVision

CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services.

General Project Business Development Office

General Project Business Development Office is a Phillipsburg, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carter Dental Lab

Carter Dental Lab is a Stuttgart, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PT Group the

PT Group the is a New Kensington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sensivida

"SensiVida Medical Technologies, Inc. is a minimally invasive Diagnostic Device company. Our patented Microsystems-based optical technology automates bio-sensing and data acquisition while minimizing patient discomfort. Our ""platform"" technology can be applied to a number of disease state diagnostics, including allergy testing, pain-free automated glucose monitoring and blood coagulation testing (e.g. for Coumadin patients), TB testing, and cholesterol monitoring."